Order Article Reprints

Gonzalez JD, Mahammad S, Beraki S, Rodriguez-Frandsen A, Sheik N, Kathirvel E, Binette F, Weinstein D, Jewett A, Chen L. Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized Mouse Models. Vaccines. 2025; 13(11):1131. https://doi.org/10.3390/vaccines13111131

Gonzalez, Jose D., Saleemulla Mahammad, Senay Beraki, Ariel Rodriguez-Frandsen, Neha Sheik, Elango Kathirvel, Francois Binette, David Weinstein, Anahid Jewett, and Lu Chen. 2025. "Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized Mouse Models" Vaccines 13, no. 11: 1131. https://doi.org/10.3390/vaccines13111131

Gonzalez, J. D., Mahammad, S., Beraki, S., Rodriguez-Frandsen, A., Sheik, N., Kathirvel, E., Binette, F., Weinstein, D., Jewett, A., & Chen, L. (2025). Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized Mouse Models. Vaccines, 13(11), 1131. https://doi.org/10.3390/vaccines13111131